Hamon Center Therapeutic Oncology - Minna Lab

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Non-Small Cell Lung Carcinoma 86%
3. Neoplasms 50%
4. Cell Line 40%
5. Genes 32%
6. Small Cell Lung Carcinoma 28%
7. Lung 26%
8. Epithelial Cells 21%
9. Adenocarcinoma of Lung 20%
10. Mutation 18%
11. Oncogenes 17%
12. Gene Expression 17%
13. Tumor Suppressor Genes 14%
14. Epithelial-Mesenchymal Transition 14%
15. ErbB Receptors 14%
16. Methylation 14%
17. Growth 14%
18. Breast Neoplasms 14%
19. Heterografts 13%
20. Carcinogenesis 12%
21. Genome 12%
22. Proteins 11%
23. Apoptosis 11%
24. Phenotype 11%
25. Therapeutics 10%
26. Biomarkers 10%
27. DNA Mismatch Repair 10%
28. Survival 9%
29. Transcriptome 9%
30. DNA Methylation 8%
31. Datasets 8%
32. Epigenomics 8%
33. DNA 8%
34. Microsatellite Instability 8%
35. Adenocarcinoma 7%
36. Poly (ADP-Ribose) Polymerase-1 7%
37. Transcription Factors 7%
38. Tumor Cell Line 7%
39. Alleles 6%
40. Messenger RNA 6%
41. Small Interfering RNA 6%
42. alpha-2'-deoxythioguanosine 6%
43. Squamous Cell Carcinoma 6%
44. In Vitro Techniques 6%
45. Pharmaceutical Preparations 6%
46. Erlotinib Hydrochloride 6%
47. Pancreatic Neoplasms 6%
48. Chromosomes 6%
49. Radiation 5%
50. Carcinoma 5%
51. Transgenic Mice 5%
52. Microsatellite Repeats 5%
53. Cell Cycle 5%
54. Loss of Heterozygosity 5%
55. Notch1 Receptor 5%
56. Cell Survival 5%
57. Neoplasm Metastasis 5%
58. Carbamyl Phosphate 5%
59. Proteomics 5%
60. Cytoplasmic and Nuclear Receptors 5%
61. Microarray Analysis 5%
62. Protein-Tyrosine Kinases 5%
63. Drug Therapy 5%
64. Genomics 5%
65. Phosphotransferases 5%
66. Single Nucleotide Polymorphism 5%
67. pyrimidine 5%
68. Neuroendocrine Tumors 5%
69. Gefitinib 5%
70. Oligonucleotide Array Sequence Analysis 5%
71. Nicotinic Receptors 5%
72. Cell Movement 5%
73. Cell Proliferation 5%